Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhihai Deng

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Medicine|October 12, 2016
Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathwayBin Pan, Weifeng Zhong, Zhihai Deng, et al.
Biomed Research International|July 30, 2019
IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc PathwayJing Chu, Yutong Li, Zhihai Deng, et al.
Frontiers in Genetics|September 20, 2021
Suppression of ANT2 by miR-137 Inhibits Prostate TumorigenesisHeyuan Zhang, Nanhui Chen, Zhihai Deng, et al.
Cancers|November 13, 2025
CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis SuppressionZhihai Deng, Qiang Shen, Nan Deng, et al.
Cell Death Discovery|December 8, 2025
CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1Yiyou Mao, Qu Leng, Jun Wu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Medicine|October 12, 2016
Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathwayBin Pan, Weifeng Zhong, Zhihai Deng, et al.
Biomed Research International|July 30, 2019
IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc PathwayJing Chu, Yutong Li, Zhihai Deng, et al.
Frontiers in Genetics|September 20, 2021
Suppression of ANT2 by miR-137 Inhibits Prostate TumorigenesisHeyuan Zhang, Nanhui Chen, Zhihai Deng, et al.
Cancers|November 13, 2025
CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis SuppressionZhihai Deng, Qiang Shen, Nan Deng, et al.
Cell Death Discovery|December 8, 2025
CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1Yiyou Mao, Qu Leng, Jun Wu, et al.
Pageof 1